Effectiveness of medical management in Adenomyosis

Navyasree Pothireddy, B. Jeyamani
In: International journal of health sciences · 2022 · pp. 11984–11992 · doi:10.53730/ijhs.v6ns5.11764 · W4291366507
article OA: diamond CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This comparative study evaluated medical management in premenopausal women with abnormal uterine bleeding due to adenomyosis confirmed by sonography.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Introduction: Adenomyosis is defined by the abnormal location of endometrial tissue within the myometrium associated with hypertrophy or hyperplasia of the myometrial stroma. It is a chronic estrogen dependent condition. Although pathogenesis and etiology of adenomyosis remain unknown, two main theories have been proposed: invagination of the endometrial basal layer and metaplasia of embryonic stem cells. Prevalence of adenomyosis varies widely from 5 to 70% with recent studies showing about 20% prevalence among which the majority were premenopausal. Materials and Methods: A Comparative Study was conducted from March 2022-August 2022. Women attending Gynec OPD with Abnormal Uterine bleeding due to Adenomyosis confirmed by sonography at Vinayaka Mission’s Kiruparananda Variyar Medical College and Hospital, Salem. Patients coming to Gynecology OPD with complaints of heavy menstrual bleeding, confirmed diagnosis of adenomyosis by ultrasonography, fulfilling the criteria and ready to followup to be enrolled in the study. A detailed history to be obtained with regard to age, parity, age of menarche, time since bleeding starts, duration and frequency of menstrual cycle.

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (10)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK